Max Healthcare updates on NCLT proceedings for Kalinga Hospital subsidiary

Regulatory & Legal View source PDF Explain this filing

MAXHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.1%Reaction day

₹1068.00

prior close

₹1070.20

announcement price

After-mkt

timing

Nifty 100market+0.1%+0.0% vs market

Hospital peers, median of 26sector-0.0%+0.1% vs sector

On the reaction day the stock moved in line with Nifty 100 and 0.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.3

15m

-0.4

30m

-0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.1+0.1+0.0-0.0+0.1

Next day

-2.6-0.3-2.3-0.7-1.9

-5.7-0.4-5.3-1.5-4.2

-5.2-0.6-4.6-3.0-2.2

-5.6-0.7-4.8-2.2-3.4

-6.0-1.0-5.0-3.3-2.7

-6.6-1.8-4.8-2.4-4.3

15d

-2.4-1.9-0.6-3.2+0.7

-2.8-4.2+1.4-1.6-1.2

-18.9-8.9-10.0-12.0-6.9

—————

UpDownMarket · Nifty 100Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Max Healthcare reported an update on NCLT Cuttack Bench proceedings involving its subsidiary Kalinga Hospital Ltd. BRS Capital Two Pte Ltd had filed petitions against KHL, the other shareholder, and the Company. At the August 4 hearing, the Company raised objections about a procedural defect (incorrect Postal Ballot Notice) in the interlocutory petition. NCLT allowed the opposite party to rectify the defect by filing an additional affidavit. Next hearing is listed for August 19, 2026.

Likely market impact

Procedural update on ongoing NCLT case tied to Kalinga Hospital subsidiary. No settlement, penalty, or financial impact disclosed. Matter continues.